391 related articles for article (PubMed ID: 24088546)
21. Characterization of ceramide synthase 2: tissue distribution, substrate specificity, and inhibition by sphingosine 1-phosphate.
Laviad EL; Albee L; Pankova-Kholmyansky I; Epstein S; Park H; Merrill AH; Futerman AH
J Biol Chem; 2008 Feb; 283(9):5677-84. PubMed ID: 18165233
[TBL] [Abstract][Full Text] [Related]
22. The effect of high-fat diet on the sphingolipid pathway of signal transduction in regenerating rat liver.
Zabielski P; Baranowski M; Błachnio-Zabielska A; Zendzian-Piotrowska M; Górski J
Prostaglandins Other Lipid Mediat; 2010 Nov; 93(3-4):75-83. PubMed ID: 20599517
[TBL] [Abstract][Full Text] [Related]
23. Activation of sphingosine kinase-1 in cancer: implications for therapeutic targeting.
Cuvillier O; Ader I; Bouquerel P; Brizuela L; Malavaud B; Mazerolles C; Rischmann P
Curr Mol Pharmacol; 2010 Jun; 3(2):53-65. PubMed ID: 20302564
[TBL] [Abstract][Full Text] [Related]
24. Sphingolipids, lipotoxic cardiomyopathy, and cardiac failure.
Park TS; Goldberg IJ
Heart Fail Clin; 2012 Oct; 8(4):633-41. PubMed ID: 22999245
[TBL] [Abstract][Full Text] [Related]
25. Sphingolipids in neurodegeneration (with focus on ceramide and S1P).
Wang G; Bieberich E
Adv Biol Regul; 2018 Dec; 70():51-64. PubMed ID: 30287225
[TBL] [Abstract][Full Text] [Related]
26. Sphingolipid signaling pathways as potential therapeutic targets in gliomas.
Van Brocklyn JR
Mini Rev Med Chem; 2007 Oct; 7(10):984-90. PubMed ID: 17979800
[TBL] [Abstract][Full Text] [Related]
27. Sphingosine-1-Phosphate Metabolism and Signaling in Kidney Diseases.
Drexler Y; Molina J; Mitrofanova A; Fornoni A; Merscher S
J Am Soc Nephrol; 2021 Jan; 32(1):9-31. PubMed ID: 33376112
[TBL] [Abstract][Full Text] [Related]
28. Multifaceted roles of sphingosine-1-phosphate: how does this bioactive sphingolipid fit with acute neurological injury?
Singh IN; Hall ED
J Neurosci Res; 2008 May; 86(7):1419-33. PubMed ID: 18058948
[TBL] [Abstract][Full Text] [Related]
29. Sphingosine-1-phosphate signaling in the cardiovascular system.
Peters SL; Alewijnse AE
Curr Opin Pharmacol; 2007 Apr; 7(2):186-92. PubMed ID: 17280869
[TBL] [Abstract][Full Text] [Related]
30. Ceramide and S1P Signaling in Embryonic Stem Cell Differentiation.
Wang G; Spassieva SD; Bieberich E
Methods Mol Biol; 2018; 1697():153-171. PubMed ID: 28540559
[TBL] [Abstract][Full Text] [Related]
31. The Role of Ceramide and Sphingosine-1-Phosphate in Alzheimer's Disease and Other Neurodegenerative Disorders.
Czubowicz K; Jęśko H; Wencel P; Lukiw WJ; Strosznajder RP
Mol Neurobiol; 2019 Aug; 56(8):5436-5455. PubMed ID: 30612333
[TBL] [Abstract][Full Text] [Related]
32. Sphingolipid metabolism and leukemia: a potential for novel therapeutic approaches.
Burns TA; Luberto C
Anticancer Agents Med Chem; 2011 Nov; 11(9):863-81. PubMed ID: 21707485
[TBL] [Abstract][Full Text] [Related]
33. Ceramide Signaling and Metabolism in Pathophysiological States of the Lung.
Petrache I; Berdyshev EV
Annu Rev Physiol; 2016; 78():463-80. PubMed ID: 26667073
[TBL] [Abstract][Full Text] [Related]
34. The control of the balance between ceramide and sphingosine-1-phosphate by sphingosine kinase: oxidative stress and the seesaw of cell survival and death.
Van Brocklyn JR; Williams JB
Comp Biochem Physiol B Biochem Mol Biol; 2012 Sep; 163(1):26-36. PubMed ID: 22613819
[TBL] [Abstract][Full Text] [Related]
35. Principles of bioactive lipid signalling: lessons from sphingolipids.
Hannun YA; Obeid LM
Nat Rev Mol Cell Biol; 2008 Feb; 9(2):139-50. PubMed ID: 18216770
[TBL] [Abstract][Full Text] [Related]
36. An update on sphingosine-1-phosphate and other sphingolipid mediators.
Fyrst H; Saba JD
Nat Chem Biol; 2010 Jul; 6(7):489-97. PubMed ID: 20559316
[TBL] [Abstract][Full Text] [Related]
37. Nuclear sphingolipid metabolism.
Lucki NC; Sewer MB
Annu Rev Physiol; 2012; 74():131-51. PubMed ID: 21888508
[TBL] [Abstract][Full Text] [Related]
38. Sphingolipid metabolism and its role in the skeletal tissues.
Khavandgar Z; Murshed M
Cell Mol Life Sci; 2015 Mar; 72(5):959-69. PubMed ID: 25424644
[TBL] [Abstract][Full Text] [Related]
39. Sphingolipid De Novo Biosynthesis: A Rheostat of Cardiovascular Homeostasis.
Sasset L; Zhang Y; Dunn TM; Di Lorenzo A
Trends Endocrinol Metab; 2016 Nov; 27(11):807-819. PubMed ID: 27562337
[TBL] [Abstract][Full Text] [Related]
40. Sphingolipid metabolites in inflammatory disease.
Maceyka M; Spiegel S
Nature; 2014 Jun; 510(7503):58-67. PubMed ID: 24899305
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
